Literature DB >> 28269508

Cross-frequency coupling during auditory perception in human cortex.

Urszula Malinowska, Dana Boatman-Reich.   

Abstract

Cross-frequency coupling plays an important role in coordinating neuronal computations underlying human perception, learning and memory. Here we compared four methods for measuring phase/amplitude coupling (PAC) of theta (4-7 Hz) and high-gamma (70-150 Hz) in intracranial electrocorticographic (ECoG) recordings. Time-frequency spectral and time-domain evoked responses were derived for comparison. All four methods showed significant increases in theta/high-gamma PAC in auditory cortex at sites where significant event-related increases in high-gamma power were also observed. Similarly, all PAC methods revealed stimulus effects (type, probability). However, the patterns of PAC increases differed across methods. Results suggest that PAC measures may be differentially sensitive to the underlying neural activity, including high-gamma amplitude, phase locking, and response timing.

Entities:  

Mesh:

Year:  2016        PMID: 28269508     DOI: 10.1109/EMBC.2016.7591977

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

1.  Motor and sensory cortical processing of neural oscillatory activities revealed by human swallowing using intracranial electrodes.

Authors:  Hiroaki Hashimoto; Kazutaka Takahashi; Seiji Kameda; Fumiaki Yoshida; Hitoshi Maezawa; Satoru Oshino; Naoki Tani; Hui Ming Khoo; Takufumi Yanagisawa; Toshiki Yoshimine; Haruhiko Kishima; Masayuki Hirata
Journal:  iScience       Date:  2021-06-25

2.  Multi-Regional Adaptation in Human Auditory Association Cortex.

Authors:  Urszula Malinowska; Nathan E Crone; Frederick A Lenz; Mackenzie Cervenka; Dana Boatman-Reich
Journal:  Front Hum Neurosci       Date:  2017-05-09       Impact factor: 3.169

3.  Cross-Frequency Coupling Based Neuromodulation for Treating Neurological Disorders.

Authors:  Yousef Salimpour; William S Anderson
Journal:  Front Neurosci       Date:  2019-02-21       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.